Title : Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.

Pub. Date : 2018 Jul

PMID : 29549391






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RATIONALE: Recent preclinical data has implicated the alpha7 nicotinic acetylcholine receptor (nAChR) as a target in modulating nicotine reward. Nicotine cholinergic receptor, nicotinic, alpha polypeptide 7 Mus musculus
2 However, the role of the channel properties of the alpha7 nAChR in nicotine withdrawal is unknown. Nicotine cholinergic receptor, nicotinic, alpha polypeptide 7 Mus musculus
3 OBJECTIVES: This study aimed to investigate the impact of alpha7 nAChR pharmacological modulation on mecamylamine-precipitated nicotine withdrawal behaviors in mice by using positive allosteric modulators (PAMs). Nicotine cholinergic receptor, nicotinic, alpha polypeptide 7 Mus musculus
4 Nicotine withdrawal signs were precipitated upon administration of the non-selective nAChR antagonist mecamylamine (3.5 mg/kg, i.p.). Nicotine cholinergic receptor, nicotinic, alpha polypeptide 7 Mus musculus
5 CONCLUSIONS: Taken together, our results suggest that modulation of the alpha7 nAChR can play important roles in mecamylamine-precipitated nicotine withdrawal behaviors in mice. Nicotine cholinergic receptor, nicotinic, alpha polypeptide 7 Mus musculus
6 These findings highlight a beneficial effect of using alpha7 nAChR PAMs in some aspects of precipitated nicotine withdrawal. Nicotine cholinergic receptor, nicotinic, alpha polypeptide 7 Mus musculus